Replies to post #177814 on Biotech Values

[dewophile]

but we're talking about a finite market opportunity since the incidence of disease today is very low despite a high prevalence. so are you saying realizing a 100B or 150B opportunity over 3-4 years versus 15 years is a bad thing?
maybe i am missing something